newsfilter
← Latest News
ACCESS Newswire·

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kiromic To Contact Him Directly To Discuss Their Options

NEW YORK, NY / ACCESSWIRE / September 15, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Kiromic BioPharma, Inc. ("Kiromic" or the "Company") (NASDAQ:KRBP) and reminds investors of the Octob